路透社8月12日消息——Onconetix Inc.（纳斯达克代码：ONCO）近日对外披露，公司已向美国证券交易委员会（SEC）提交相关文件，计划允许特定股东对最多1亿股普通股进行转售。这一举措源自公司最新提交的证券注册声明，旨在为售股股东提供股份流通的通道。此次转售安排不涉及公司直接发行新股，而是由现有股东将其持有的股份在公开市场上进行处置。市场人士对此反应不一，但普遍关注该事件可能对股价带来的短期波动影响。
路透社8月12日消息——Onconetix Inc.（纳斯达克代码：ONCO）近日对外披露，公司已向美国证券交易委员会（SEC）提交相关文件，计划允许特定股东对最多1亿股普通股进行转售。这一举措源自公司最新提交的证券注册声明，旨在为售股股东提供股份流通的通道。此次转售安排不涉及公司直接发行新股，而是由现有股东将其持有的股份在公开市场上进行处置。市场人士对此反应不一，但普遍关注该事件可能对股价带来的短期波动影响。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.